POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.DNA polymerase theta (POLQ) is a prognostic factor in pancreatic cancer. Higher POLQ expression correlates with poorer survival, indicating its potential as a biomarker for patient outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- DNA polymerase theta (POLQ) is crucial for DNA repair via the Theta Mediated End Joining (TMEJ) pathway.
- POLQ overexpression is linked to cancer progression and poor prognosis in various cancers.
- The prognostic value of POLQ in pancreatic cancer has not been previously investigated.
Purpose Of The Study
- To investigate the utility of POLQ H-score as a prognostic biomarker in pancreatic cancer.
- To analyze the correlation between POLQ gene expression and patient survival outcomes.
Main Methods
- Evaluated POLQ mRNA levels using the GEPIA web tool with TCGA and GTEx data.
- Assessed POLQ protein expression via immunohistochemistry (IHC) in 152 biliopancreatic cancer specimens.
- Correlated survival data with POLQ expression using Kaplan-Meier curves and Cox regression analysis.
Main Results
- GEPIA analysis revealed significant associations between POLQ mRNA levels and both Disease Free Survival (DFS) and Overall Survival (OS).
- Immunohistochemistry showed that POLQ H-score was significantly linked to OS in Kaplan-Meier and Cox regression analyses.
- Higher POLQ expression correlated with poorer survival outcomes in pancreatic cancer patients.
Conclusions
- POLQ serves as an independent prognostic factor in pancreatic cancer.
- Both gene expression analysis (GEPIA) and protein level assessment (IHC) support POLQ's role as a prognostic indicator.
- POLQ is a potential biomarker for predicting patient prognosis in pancreatic cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.